ASX-Listed Aroa Biosurgery climbs on higher annual revenue
26/04/2022 07:01
** Shares of Aroa Biosurgery ARX.AX rise as much as 5.1%
to A$0.92, highest since Feb. 11
** New Zealand-based soft tissue repair company posts prelim
unaudited total revenue of NZ$39.7 mln ($26.37 mln) for FY22, up
78% urn:newsml:reuters.com:*:nFWN2WN1AX
** Company says its prelim unaudited FY22 product revenue
rose 84% to NZ$39.2 mln
** Stock down 14.2% this year, as of last close
($1 = 1.5056 New Zealand dollars)
(Reporting by Navya Mittal in Bengaluru)
((navya.mittal@thomsonreuters.com))